Veni for researcher Patrick Deelen
Dr Patrick Deelen of the Department of Genetics of the UMCG has been awarded an NWO Veni grant of 250.000 euro for scientific research. The Veni grant enables young, talented researchers to develop their ideas further for a period of three years.
Patrick's Veni research project, The Shared Focal Point of Common Diseases and Rare Diseases, aims to integrate current knowledge about the genetic causes of common diseases with bioinformatic gene networks to predict which genes cause rare disease. The ultimate goal of this work is to enable a genetic diagnosis for the approximately 60% of patients suspected of having genetic disorders who currently go without a diagnosis.
The Veni, together with the Vidi and Vici, is part of the Innovational Reseach Incentives Scheme of the NWO, Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Dutch Research Council). The aim of the programme is to foster innovative research. The Veni grants are personal grants and awarded by the NOW annually. See www.NWO for more information.
| Last modified: | 10 November 2020 1.49 p.m. |
More news
-
15 June 2021
From ‘closed’ science to Open Science
Vera Heininga is the Open Science coordinator and future programme leader of the upcoming Open Science programme of the University of Groningen. Together with her colleagues, she created the Open Science Community Groningen (OSCG). She explains...
-
17 May 2021
‘Encouraging young people, that’s my most important job’
Four and a half years ago, he received the Nobel Prize. During the award ceremony in Stockholm, Ben Feringa made a resolution: I will put science on the map. His mission is being given a new boost with the establishment of the Ben Feringa Fund,...
-
10 May 2021
‘Give people with dementia more freedom to organize their own social lives’
Older people with memory problems who live at home are extraordinarily resourceful when it comes to staying in control of their activities outside the home. Demographers Jodi Sturge and Mirjam Klaassens are certainly impressed. ‘It’s not about...